Stevens P A, Schadow B, Bartholain S, Segerer H, Obladen M
Department of Neonatology, University Children's Hospital, Free University Berlin, Federal Republic of Germany.
Eur J Pediatr. 1992 Aug;151(8):596-600. doi: 10.1007/BF01957730.
Surfactant-associated protein (SP-A) was measured in tracheal aspirates of ventilated infants with (n = 51) and without (n = 21) respiratory distress syndrome (RDS). SP-A concentrations in samples collected after birth were significantly lower in RDS than in infants ventilated for other reasons than RDS (median 0.03 vs. 1.60 micrograms/ml). As a biochemical test to diagnose RDS early after birth, the sensitivity of measuring SP-A in tracheal aspirates was 87% and specificity 81%. SP-A content in tracheal aspirates of infants with RDS was monitored during the first 7 days of life. A significant (P less than 0.001) increase within the first 4 days was found in those infants who survived, whereas no such change was found in those infants who died.
在患有呼吸窘迫综合征(RDS)(n = 51)和未患呼吸窘迫综合征(n = 21)的通气婴儿的气管吸出物中测量了表面活性物质相关蛋白(SP-A)。出生后采集的样本中,RDS婴儿的SP-A浓度显著低于因其他原因而非RDS进行通气的婴儿(中位数分别为0.03微克/毫升和1.60微克/毫升)。作为出生后早期诊断RDS的生化检测方法,测量气管吸出物中SP-A的敏感性为87%,特异性为81%。在出生后的前7天对患有RDS的婴儿的气管吸出物中的SP-A含量进行了监测。存活的婴儿在出生后的前4天内出现了显著增加(P<0.001),而死亡的婴儿则没有这种变化。